Concord Drugs informs about disclosure

25 Nov 2025 Evaluate
Concord Drugs has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Nagi Reddy.

The above information is a part of company’s filings submitted to BSE.

Concord Drugs Share Price

83.41 2.56 (3.17%)
04-Feb-2026 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.10
Dr. Reddys Lab 1243.65
Cipla 1332.00
Zydus Lifesciences 911.30
Lupin 2197.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×